A detailed history of Wells Fargo & Company transactions in Liquidia Corp stock. As of the latest transaction made, Wells Fargo & Company holds 23,455 shares of LQDA stock, worth $254,017. This represents 0.0% of its overall portfolio holdings.

Number of Shares
23,455
Previous 16,662 40.77%
Holding current value
$254,017
Previous $245,000 14.69%
% of portfolio
0.0%
Previous 0.0%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$11.96 - $15.71 $81,244 - $106,718
6,793 Added 40.77%
23,455 $281,000
Q1 2024

May 10, 2024

BUY
$11.35 - $16.73 $34,980 - $51,561
3,082 Added 22.7%
16,662 $245,000
Q4 2023

Feb 09, 2024

BUY
$5.77 - $12.19 $18,614 - $39,324
3,226 Added 31.16%
13,580 $163,000
Q3 2023

Nov 13, 2023

SELL
$6.27 - $8.15 $56,116 - $72,942
-8,950 Reduced 46.36%
10,354 $65,000
Q2 2023

Aug 15, 2023

BUY
$6.63 - $9.9 $68,633 - $102,484
10,352 Added 115.64%
19,304 $151,000
Q1 2023

May 12, 2023

BUY
$5.72 - $7.91 $51,205 - $70,810
8,952 New
8,952 $61,000
Q3 2022

Nov 14, 2022

SELL
$3.73 - $8.39 $1,883 - $4,236
-505 Reduced 45.83%
597 $3,000
Q2 2022

Aug 12, 2022

SELL
$3.37 - $7.55 $82,854 - $185,624
-24,586 Reduced 95.71%
1,102 $5,000
Q1 2022

May 16, 2022

BUY
$5.14 - $7.38 $117,860 - $169,223
22,930 Added 831.4%
25,688 $185,000
Q4 2021

Feb 14, 2022

BUY
$2.71 - $5.17 $6,775 - $12,925
2,500 Added 968.99%
2,758 $13,000
Q3 2021

Nov 15, 2021

BUY
$2.28 - $2.95 $38 - $50
17 Added 7.05%
258 $1,000
Q2 2021

Aug 16, 2021

SELL
$2.51 - $3.11 $21,646 - $26,820
-8,624 Reduced 97.28%
241 $1,000
Q1 2021

May 13, 2021

SELL
$2.42 - $3.6 $105,608 - $157,104
-43,640 Reduced 83.12%
8,865 $24,000
Q4 2020

Feb 09, 2021

BUY
$2.6 - $5.79 $40,024 - $89,131
15,394 Added 41.48%
52,505 $154,000
Q3 2020

Nov 05, 2020

BUY
$4.34 - $8.28 $6,162 - $11,757
1,420 Added 3.98%
37,111 $183,000
Q2 2020

Aug 13, 2020

BUY
$4.86 - $11.44 $96,330 - $226,752
19,821 Added 124.9%
35,691 $300,000
Q1 2020

May 14, 2020

BUY
$3.31 - $7.15 $52,529 - $113,470
15,870 New
15,870 $75,000

Others Institutions Holding LQDA

About Liquidia Corp


  • Ticker LQDA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 64,362,300
  • Market Cap $697M
  • Description
  • Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension. It also distributes generic treprostinil inje...
More about LQDA
Track This Portfolio

Track Wells Fargo & Company Portfolio

Follow Wells Fargo & Company and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.